寨卡病毒检测市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

市场按测试类型(分子测试和血清学测试)、最终用户和地理细分

市场快照

Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

已知寨卡病毒 (ZIKV) 感染在非洲和东南亚流行。随之而来的病毒在太平洋地区的传播导致了全球发达国家和新兴国家的爆发。根据世界卫生组织 (WHO) 的数据,大约 84 个国家/地区已经或曾经感染过 ZIKV 传播。亚太地区(尤其是印度)和南美国家曾爆发过寨卡病毒感染的大规模爆发。根据疾病控制和预防中心的数据,墨西哥、南美洲、中部和撒哈拉以南非洲国家以及东南亚的一些国家是寨卡病毒感染增长的主要风险国家。因此,在预测期内,寨卡病毒感染率的上升是推动所研究市场增长的主要因素之一。

研究市场的其他主要驱动力是生物制药公司增加研发,以及诊断测试的技术进步。

报告范围

寨卡病毒属于由白天叮咬的伊蚊传播的黄病毒属。市场范围包括按测试类型和最终用户划分的市场细分。

By Test Type
Molecular Test
Serologic Test
By End User
Hospital/Clinic
Diagnostics Laboratory
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

预计血清学测试部分将在预测年份显示出更好的增长

寨卡病毒测试市场已根据测试类型和最终用户进行细分。测试类型进一步细分为分子测试和血清学测试。由于他们的偏好增加,血清学测试预计会增长,因为他们可以检测急性和晚期寨卡病毒感染。此外,新兴的快速检测血清学诊断提供更短的周转时间以及寨卡病毒与其他黄病毒的鉴别诊断。此外,怀孕早期的寨卡病毒会增加出生缺陷的风险。根据疾病预防控制中心的数据,在怀孕的前三个月,母亲感染寨卡病毒的婴儿中报告出生缺陷病例的比例较高。该病毒可以从受感染的孕妇传播给胎儿,并导致小头畸形和其他严重的脑部异常。

Zika Virus Testing Market 1

北美主导市场,预计在预测期内将遵循同样的趋势

预计北美将主导所研究的市场。这种增长可归因于人们对检测试剂盒优势的认识不断提高。疾病控制和预防中心(CDC)、泛美卫生组织(PAHO)等政府机构主要参与了寨卡病毒感染的预防工作。根据美国疾病控制与预防中心的数据,美国各州在怀孕期间确诊寨卡病毒感染的妇女中,每 20 名婴儿中约有 2 名 (10%) 患有与寨卡病毒相关的出生缺陷,而在美国领土内,每 20 名妇女中约有 1 名 (5%) 婴儿患有寨卡相关出生缺陷。疾病预防控制中心已获得资金,以对抗多个地区的寨卡病毒爆发。此外,发达的医疗保健基础设施,以及几家生物制药公司在寨卡病毒测试方面的快速技术进步,预计将对市场产生积极影响。

Zika Virus Testing Market 2

竞争格局

寨卡病毒检测市场的全球参与者包括 Abbott Laboratories、Altona Diagnostics GmbH、Chembio Diagnostic Systems Inc.、ELITechGroup、F. Hoffmann-La Roche Ltd、Genekam、Luminex Corporation、Novacyt Group、Quest Diagnostics 和 Siemens AG。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Zika Virus Infection

      2. 4.2.2 Increasing R&D by Biopharmaceutical Companies

      3. 4.2.3 Technological Advancements

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Testing Kits

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Test Type

      1. 5.1.1 Molecular Test

      2. 5.1.2 Serologic Test

    2. 5.2 By End User

      1. 5.2.1 Hospital/Clinic

      2. 5.2.2 Diagnostics Laboratory

      3. 5.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Altona Diagnostics GmbH

      3. 6.1.3 Chembio Diagnostic Systems Inc.

      4. 6.1.4 ELITechGroup

      5. 6.1.5 F. Hoffmann-La Roche Ltd

      6. 6.1.6 Genekam

      7. 6.1.7 Luminex Corporation

      8. 6.1.8 Novacyt Group

      9. 6.1.9 Quest Diagnostics

      10. 6.1.10 Siemens AG

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Zika Virus Testing Market market is studied from 2018 - 2026.

The Zika Virus Testing Market is growing at a CAGR of 5.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Abbott Laboratories, F. Hoffmann-La Roche Ltd, Luminex Corporation, Quest Diagnostics, Siemens AG are the major companies operating in Zika Virus Testing Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!